US 12203072
Chemically modified single-stranded rna-editing oligonucleotides
granted A61PA61P1/04A61P11/06
Quick answer
US patent 12203072 (Chemically modified single-stranded rna-editing oligonucleotides) held by ProQR Therapeutics II B.V. expires Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ProQR Therapeutics II B.V.
- Grant date
- Tue Jan 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61P, A61P1/04, A61P11/06, A61P17/00, A61P21/00